In recent years, a large number of drugs have been developed for the treatment of glaucoma. The clinical use of drugs for glaucoma therapy has evolved, adapting with the advent of each new drug. Clinicians need to understand, synthesize, and use data about medications that have specific benefits and risks for their glaucoma patients. The focus of this book is the current art and science of clinically available drugs for medical therapy of glaucoma. The contributors have attempted to provide evidence-based information about the topic, while providing perspective from clinical experience. The book is intended to provide information about glaucoma medical therapy for practicing ophthalmologists and ophthalmologists in training. Other practitioners who have clinical contact with glaucoma patients also may find the content of this monograph valuable. In the second edition of this book, all chapters have been thoroughly revised and updated, and new chapters regarding fixed combination drugs and medical treatment of pediatric patients have been added. Some chapters have required addition of extensive new material because of the changes in medical therapy of glaucoma since the publication of the first edition of the book in 1999.
Copying to clipboard limited to 5 samples
Keywords: glaucoma, patients, clinically available drugs, medical therapy, clinical experience